ChartRow logo
Sign in
TEVA
Teva Pharmaceutical Industries Limited American Depositary SharesStock · Health Care
$34.81+$0.09 (+0.26%)as of market close, Aug 6, 2026
CompareLLYUNHJNJABBVISRGTMO

How Teva Pharmaceutical Industries Limited American Depositary Shares uses its cash

Period

Where does Teva Pharmaceutical Industries Limited American Depositary Shares's cash go? This Sankey traces cash from net income through operating cash flow into capex, free cash flow, dividends, buybacks, and debt paydown. Pick any fiscal year, recent quarter, or the trailing twelve months. Straight from SEC filings.

Teva Pharmaceutical Industries Limited American Depositary Shares · FY2025 · year ended 2025-12-31
Operating cash flow$1.6BCash from operations$2.6B · 156%Net income$1.4B · 86%D&A$1.0B · 61%Stock comp$157M · 10%Working capital$920M · 56%Capex$501M · 30%Free cash flow$1.1B · 70%Debt repaid$1.8B · 110%Cash reserves$666M · 40%

Each fiscal year from SEC filings. Percentages are share of operating cash flow. Sources (net income + non-cash add-backs) flow into operating cash flow, which splits into capex and free cash flow; free cash flow goes to dividends, buybacks, debt paydown, and what's retained. Annual only. For informational purposes only.